ORAL CONTRACEPTIVES WITH ESTROGEN LEVELS ABOVE 50 MCG SHOULD BE DISCONTINUED FOR USE IN CONTRACEPTION, FDA ADVISORY COMMITTEE RECOMMENDS ON JAN. 15

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".